Given these considerations, we hypothesised that high plasma levels of MMP-9 and its inhibitor TIMP-1 as well as NGAL can be related to chronic microvascular complications in individuals with type 1 diabetes, such as diabetes nephropathy and diabetes neuropathy. This evidence concerns the gene TIMP1 and diabetic neuropathy.